Regenerative Therapies Market

Global Market Study on Regenerative Therapies: North America Holds More than Half Global Market Share

Regenerative Therapies Market Segmented By Allograft, Xenograft, Alloplast Tissue Type in Soft Tissue Repair, Cardiovascular, Dental, Orthopedic, CNS disease treatment,

  • July-2021
  • PMRREP10598
  • 224 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

Table of Content

 

1. Global Regenerative Therapies Market - Executive Summary

 

2. Assumptions and Acronyms Used

 

3. Research Methodology

 

4. Global Regenerative Therapies Market Overview
4.1. Introduction
     4.1.1. Regenerative Therapies Market Definition
     4.1.2. Regenerative Therapies Market Taxonomy
4.2. Regenerative Therapies Market Application Overview
4.3. Parent Market Overview
4.4. Regenerative Therapies Market Dynamics
     4.4.1. Drivers
     4.4.2. Restraints
     4.4.3. Opportunity
     4.4.4. Value Chain
4.5. Global Regenerative Therapies Market Forecast, 2021-2031
     4.5.1. Market Value Forecast
     4.5.2. Y-o-Y Growth Projections
     4.5.3. Absolute $ Opportunity
4.6. Regenerative Therapies Market Trends
4.7. Global Regenerative Therapies Market Snapshot (2021)
     4.7.1. Market Share, By Application
     4.7.2. Market Share, By End User
     4.7.3. Market Share, By Product
     4.7.4. Market Share, By Region

 

5. Global Regenerative Therapies Market Analysis, By Tissue Type
5.1. Introduction
     5.1.1. Y-o-Y Growth Comparison, By Tissue Type
     5.1.2. Market Share & Basis Point (BPS) Analysis, By Tissue Type
5.2. Market Forecast, By Tissue Type
     5.2.1. Allograft
            5.2.1.1. Absolute $ Opportunity
            5.2.1.2. Market Value Forecast, By Region
     5.2.2. Xenograft
            5.2.2.1. Absolute $ Opportunity
            5.2.2.2. Market Value Forecast, By Region
     5.2.3. Alloplast
            5.2.3.1. Absolute $ Opportunity
            5.2.3.2. Market Value Forecast, By Region
5.3. Market Attractiveness Analysis, By Tissue Type
5.4. Prominent Trends

 

6. Global Regenerative Therapies Market Analysis, By Application
6.1. Introduction
     6.1.1. Y-o-Y Growth Comparison, By Application
     6.1.2. Market Share & Basis Point (BPS) Analysis, By Application
6.2. Market Forecast, By Application
     6.2.1. Soft Tissue Repair
            6.2.1.1. Absolute $ Opportunity
            6.2.1.2. Market Value Forecast, By Region
     6.2.2. Cardiovascular
            6.2.2.1. Absolute $ Opportunity
            6.2.2.2. Market Value Forecast, By Region
     6.2.3. Dental
            6.2.3.1. Absolute $ Opportunity
            6.2.3.2. Market Value Forecast, By Region
     6.2.4. Orthopedic
            6.2.4.1. Absolute $ Opportunity
            6.2.4.2. Market Value Forecast, By Region
     6.2.5. CNS disease treatment
            6.2.5.1. Absolute $ Opportunity
            6.2.5.2. Market Value Forecast, By Region
     6.2.6. Others
            6.2.6.1. Absolute $ Opportunity
            6.2.6.2. Market Value Forecast, By Region
6.3. Market Attractiveness Analysis, By Application
6.4. Prominent Trends

 

7. Global Regenerative Therapies Market Analysis, By End User
7.1. Introduction
     7.1.1. Y-o-Y Growth Comparison, By End User
     7.1.2. Market Share & Basis Point (BPS) Analysis, By End User
7.2. Market Forecast, By End User
     7.2.1. Hospitals
            7.2.1.1. Absolute $ Opportunity
            7.2.1.2. Market Value Forecast, By Region
     7.2.2. Ambulatory Surgical Centers
            7.2.2.1. Absolute $ Opportunity
            7.2.2.2. Market Value Forecast, By Region
     7.2.3. Educational Institutes
            7.2.3.1. Absolute $ Opportunity
            7.2.3.2. Market Value Forecast, By Region
7.3. Market Attractiveness Analysis, By End User
7.4. Prominent Trends

 

8. Global Regenerative Therapies Market Analysis, By Region
8.1. Introduction
     8.1.1. Y-o-Y Growth Projections, By Region
     8.1.2. Market Share & Basis Point (BPS) Analysis, By Region
8.2. Market Forecast, By Region
     8.2.1. North America Market Value Forecast
     8.2.2. Latin America Market Value Forecast
     8.2.3. Europe Market Value Forecast
     8.2.4. Asia Pacific Market Value Forecast
     8.2.5. MEA Market Value Forecast
8.3. Regional Attractiveness Analysis

 

9. North America Regenerative Therapies Market Analysis
9.1. Introduction
     9.1.1. Y-o-Y Growth Projections, By Country
     9.1.2. Market Share & Basis Point (BPS) Analysis, By Country
     9.1.3. Key Regulations
     9.1.4. Key Trends
9.2. North America Market Forecast
     9.2.1. Market Value Forecast, By Country
            9.2.1.1. US Absolute $ Opportunity
            9.2.1.2. Canada Absolute $ Opportunity
9.3. Market Value Forecast, By Tissue Type
     9.3.1. Allograft
     9.3.2. Xenograft
     9.3.3. Alloplast
9.4. Market Value Forecast, By Application
     9.4.1. Soft Tissue Repair
     9.4.2. Cardiovascular
     9.4.3. Dental
     9.4.4. Orthopedic
     9.4.5. CNS disease treatment
     9.4.6. Others
9.5. Market Value Forecast, By End User
     9.5.1. Hospitals
     9.5.2. Ambulatory Surgical Centers
9.5.3. Educational Institutes
9.6. Market Attractiveness Analysis
     9.6.1. By Country
     9.6.2. By Tissue Type
     9.6.3. By Application
     9.6.4. By End User
9.7. Drivers & Restraints: Impact Analysis

 

10.1. Introduction
     10.1.1. Y-o-Y Growth Projections, By Country
     10.1.2. Market Share & Basis Point (BPS) Analysis, By Country
     10.1.3. Key Regulations
     10.1.4. Key Trends
10.2. Latin America Market Forecast
     10.2.1. Market Value Forecast, By Country
            10.2.1.1. Brazil Absolute $ Opportunity
            10.2.1.2. Mexico Absolute $ Opportunity
            10.2.1.3. Rest of Latin America Absolute $ Opportunity
10.3. Market Value Forecast, By Tissue Type
     10.3.1. Allograft
     10.3.2. Xenograft
     10.3.3. Alloplast
10.4. Market Value Forecast, By Application
     10.4.1. Soft Tissue Repair
     10.4.2. Cardiovascular
     10.4.3. Dental
     10.4.4. Orthopedic
     10.4.5. CNS disease treatment
     10.4.6. Others
10.5. Market Value Forecast, By End User
     10.5.1. Hospitals
     10.5.2. Ambulatory Surgical Centers
     10.5.3. Educational Institutes
10.6. Market Attractiveness Analysis
     10.6.1. By Country
     10.6.2. By Tissue Type
     10.6.3. By Application
     10.6.4. By End User
10.7. Drivers & Restraints: Impact Analysis

 

11.  Europe Regenerative Therapies Market Analysis
11.1. Introduction
     11.1.1. Y-o-Y Growth Projections, By Country / Region
     11.1.2. Market Share & Basis Point (BPS) Analysis, By Country / Region
     11.1.3. Key Regulations
     11.1.4. Key Trends
11.2. Europe Market Forecast
     11.2.1. Market Value Forecast, By Country/Region
            11.2.1.1. Germany Absolute $ Opportunity
            11.2.1.2. United Kingdom Absolute $ Opportunity
            11.2.1.3. France Absolute $ Opportunity
            11.2.1.4. Rest of Western Europe Absolute $ Opportunity
11.3. Market Value Forecast, By Tissue Type
     11.3.1. Allograft
     11.3.2. Xenograft
     11.3.3. Alloplast
11.4. Market Value Forecast, By Application
     11.4.1. Soft Tissue Repair
     11.4.2. Cardiovascular
     11.4.3. Dental
     11.4.4. Orthopedic
     11.4.5. CNS disease treatment
     11.4.6. Others
11.5. Market Value Forecast, By End User
     11.5.1. Hospitals
     11.5.2. Ambulatory Surgical Centers
     11.5.3. Educational Institutes
11.6. Market Attractiveness Analysis
     11.6.1. By Country
     11.6.2. By Tissue Type
     11.6.3. By Application
     11.6.4. By End User
11.7. Drivers & Restraints: Impact Analysis

 

12.  Asia Pacific Regenerative Therapies Market Analysis
12.1. Introduction
     12.1.1. Y-o-Y Growth Projections, By Country
     12.1.2. Market Share & Basis Point (BPS) Analysis, By Country / Region
     12.1.3. Key Regulations
     12.1.4. Key Trends
12.2. Asia Pacific Market Forecast
     12.2.1. Market Value Forecast, By Country/Region
            12.2.1.1. Greater China Absolute $ Opportunity
            12.2.1.2. India Absolute $ Opportunity
            12.2.1.3. Japan Absolute $ Opportunity
            12.2.1.4. Singapore Absolute $ Opportunity
            12.2.1.5. Australia and New Zealand Absolute $ Opportunity
            12.2.1.6. Rest of APAC Absolute $ Opportunity
12.3. Market Value Forecast, By Tissue Type
     12.3.1. Allograft
     12.3.2. Xenograft
     12.3.3. Alloplast
12.4. Market Value Forecast, By Application
     12.4.1. Soft Tissue Repair
     12.4.2. Cardiovascular
     12.4.3. Dental
     12.4.4. Orthopedic
     12.4.5. CNS disease treatment
     12.4.6. Others
12.5. Market Value Forecast, By End User
     12.5.1. Hospitals
     12.5.2. Ambulatory Surgical Centers
     12.5.3. Educational Institutes
12.6. Market Attractiveness Analysis
     12.6.1. By Country
     12.6.2. By Tissue Type
     12.6.3. By Application
     12.6.4. By End User
12.7. Drivers & Restraints: Impact Analysis

 

13.  MEA Regenerative Therapies Market Analysis
13.1. Introduction
     13.1.1. Y-o-Y Growth Projections, By Country / Region
     13.1.2. Market Share & Basis Point (BPS) Analysis, By Country / Region
     13.1.3. Key Regulations
     13.1.4. Key Trends
13.2. MEA Market Forecast
     13.2.1. Market Value Forecast, By Country/Region
            13.2.1.1. GCC Absolute $ Opportunity
            13.2.1.2. South Africa Absolute $ Opportunity
            13.2.1.3. Rest of MEA Absolute $ Opportunity
13.3. Market Value Forecast, By Tissue Type
     13.3.1. Allograft
     13.3.2. Xenograft
     13.3.3. Alloplast
13.4. Market Value Forecast, By Application
     13.4.1. Soft Tissue Repair
     13.4.2. Cardiovascular
     13.4.3. Dental
     13.4.4. Orthopedic
     13.4.5. CNS disease treatment
     13.4.6. Others
13.5. Market Value Forecast, By End User
     13.5.1. Hospitals
     13.5.2. Ambulatory Surgical Centers
     13.5.3. Educational Institutes
13.6. Market Attractiveness Analysis
     13.6.1. By Country
     13.6.2. By Tissue Type
     13.6.3. By Application
     13.6.4. By End User
13.7. Drivers & Restraints: Impact Analysis

 

14.1. Competition Dashboard
14.2. Company Profiles
     14.2.1. Revenue
     14.2.2. Products/Brand Offerings
     14.2.3. Key developments
     14.2.4. SWOT Analysis
14.3. Company Highlights
     14.3.1. Shire Pharmaceuticals
     14.3.2. Kinetic Concepts, Inc.
     14.3.3. Mesoblast Ltd.
     14.3.4. Cytomedix Inc.
     14.3.5. Advanced Cell Technology, Inc.
     14.3.6. Organovo Holdings Inc.
     14.3.7. Orgenesis Inc.
     14.3.8. Genzyme
     14.3.9. Athersys, Inc.
     14.3.10.Cytori Therapeutics, Inc.

Find Out More about the Report Coverage

List of Tables

List of Tables

Table 01: Global Regenerative Therapies Market Value, by Tissue Type, 2017–2031 (US$ Mn)

Table 02: Global Regenerative Therapies Market Value, by Application, 2017–2031 (US$ Mn)

Table 03: Global Regenerative Therapies Market Value, by End User, 2017–2031 (US$ Mn)

Table 04: Global Regenerative Therapies Market Value, by Region, 2017–2031 (US$ Mn)

Table 05: North America Regenerative Therapies Market Value, by Application, 2017–2031 (US$ Mn)

Table 06: North America Regenerative Therapies Market Value, by End User, 2017–2031 (US$ Mn)

Table 07: Latin America Regenerative Therapies Market Value, by Application, 2017–2031 (US$ Mn)

Table 08: Latin America Regenerative Therapies Market Value, by End User, 2017–2031 (US$ Mn)

Table 09: Europe Regenerative Therapies Market Value, by Application, 2017–2031 (US$ Mn)

Table 10: Europe Regenerative Therapies Market Value, by End User, 2017–2031 (US$ Mn)

Table 11: APAC Regenerative Therapies Market Value, by Application, 2017–2031 (US$ Mn)

Table 12: APAC Regenerative Therapies Market Value, by End User, 2017–2031 (US$ Mn)

Table 13: MEA Regenerative Therapies Market Value, by Application, 2017–2031 (US$ Mn)

Table 14: APAC Regenerative Therapies Market Value, by End User, 2017–2031 (US$ Mn)

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

List of Figures

Figure 1: Global Regenerative Therapies Market Value Share & BPS Analysis, by Tissue Type, 2021, 2022 & 2031

Figure 2: Global Regenerative Therapies Market Y-o-Y Growth Comparison, by Tissue Type, 2021 – 2031

Figure 3: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Allografts Tissue type, 2017 – 2031

Figure 4: Global Regenerative Therapies Market Absolute $ Opportunity, by Allografts Tissue type, 2017 – 2031

Figure 5: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Xenografts, 2017 – 2031

Figure 6: Global Regenerative Therapies Market Absolute $ Opportunity, by Xenografts, 2017 – 2031

Figure 7: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Alloplast, 2017 – 2031

Figure 8: Global Regenerative Therapies Market Absolute $ Opportunity, by Alloplast, 2017 – 2031

Figure 9: Global Regenerative Therapies Market Attractiveness Analysis, by Tissue Type, 2022 – 2031

Figure 10: Global Regenerative Therapies Market Value Share & BPS Analysis, by Application, 2021, 2022 & 2031

Figure 11: Global Regenerative Therapies Market Y-o-Y Growth Comparison, by Application, 2021 – 2031

Figure 12: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Soft Tissue Repair, 2017 – 2031

Figure 13: Global Regenerative Therapies Market Absolute $ Opportunity, by Soft Tissue Repair, 2017 – 2031

Figure 14: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Cardiovascular, 2017 – 2031

Figure 15: Global Regenerative Therapies Market Absolute $ Opportunity, by Cardiovascular, 2017 – 2031

Figure 16: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Dental, 2022 – 2031

Figure 17: Global Regenerative Therapies Market Absolute $ Opportunity, by Dental, 2017 – 2031

Figure 18: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Orthopedic , 2017 – 2031

Figure 19: Global Regenerative Therapies Market Absolute $ Opportunity, by Orthopedic, 2017 – 2031

Figure 20: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by CNS disease treatment , 2017 – 2031

Figure 21: Global Regenerative Therapies Market Absolute $ Opportunity, by CNS disease treatment, 2022 – 2031

Figure 22: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Others, 2017 – 2031

Figure 23: Global Regenerative Therapies Market Absolute $ Opportunity, by Others , 2017 – 2031

Figure 24: Global Regenerative Therapies Market Attractiveness Analysis, by Application, 2022 – 2031

Figure 25: Global Regenerative Therapies Market Value Share & BPS Analysis, by End User, 2021, 2022 & 2031

Figure 26: Global Regenerative Therapies Market Y-o-Y Growth Comparison, by End User, 2021 – 2031

Figure 27: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Hospital Pharmacies, 2017 – 2031

Figure 28: Global Regenerative Therapies Market Absolute $ Opportunity, by Hospital Pharmacies, 2017 – 2031

Figure 29: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017 – 2031

Figure 30: Global Regenerative Therapies Market Absolute $ Opportunity, by Ambulatory Surgical Centers, 2017 – 2031

Figure 31: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Educational Institutes, 2017 – 2031

Figure 32: Global Regenerative Therapies Market Absolute $ Opportunity, by Educational Institutes, 2017 – 2031

Figure 33: Global Regenerative Therapies Market Attractiveness Analysis, by End User, 2022 – 2031

Figure 34: Global Regenerative Therapies Market Value Share & BPS Analysis, by Region, 2022 & 2031

Figure 35: Global Regenerative Therapies Market Y-o-Y Growth Comparison, by Region, 2022 – 2031

Figure 36: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), 2017 – 2031

Figure 37: North America Regenerative Therapies Market Absolute $ Opportunity, 2017 – 2031

Figure 38: Latin America Regenerative Therapies Market Value & Y-o-Y Growth (%), 2017 – 2031

Figure 39: Latin America Regenerative Therapies Market Absolute $ Opportunity, 2017 – 2031

Figure 40: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), 2017 – 2031

Figure 41: Europe Regenerative Therapies Market Absolute $ Opportunity, 2017 – 2031

Figure 42: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), 2017 – 2031

Figure 43: APAC Regenerative Therapies Market Absolute $ Opportunity, 2017 – 2031

Figure 44: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), 2017 – 2031

Figure 45: MEA Regenerative Therapies Market Absolute $ Opportunity, 2017 – 2031

Figure 46: Global Regenerative Therapies Market Attractiveness Analysis, by Region, 2022 – 2031

Figure 47: North America Regenerative Therapies Market Value Share & BPS Analysis, by Country, 2022 & 2031

Figure 48: North America Regenerative Therapies Market Y-o-Y Growth Comparison, by Country, 2022 – 2031

Figure 49: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by the U.S., 2017 – 2031

Figure 50: North America Regenerative Therapies Market Absolute $ Opportunity, by the U.S., 2017 – 2031

Figure 51: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Canada, 2017 – 2031

Figure 52: North America Regenerative Therapies Market Absolute $ Opportunity, by Canada, 2017 – 2031

Figure 53: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Allograft tissue type segment, 2017 – 2031

Figure 54: North America Regenerative Therapies Market Absolute $ Opportunity, by Allograft tissue type segment, 2017 – 2031

Figure 55: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Xenograft tissue type segment, 2017 – 2031

Figure 56: North America Regenerative Therapies Market Absolute $ Opportunity, by Xenograft tissue type segment, 2017 – 2031

Figure 57: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Alloplast tissue type segment, 2017 – 2031

Figure 58: North America Regenerative Therapies Market Absolute $ Opportunity, by Alloplast tissue type segment, 2017 – 2031

Figure 59: North America Regenerative Therapies Market Attractiveness Analysis, by Country, 2022 – 2031

Figure 60: North America Regenerative Therapies Market Attractiveness Analysis, by Application, 2022 – 2031

Figure 61: North America Regenerative Therapies Market Attractiveness Analysis, by End User, 2022 – 2031

Figure 62: Latin America Regenerative Therapies Market Value Share & BPS Analysis, by Country, 2022 & 2031

Figure 63: Latin America Regenerative Therapies Market Y-o-Y Growth Comparison, by Country, 2021 – 2031

Figure 64: Latin America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Brazil, 2017 – 2031

Figure 65: Latin America Regenerative Therapies Market Absolute $ Opportunity, by Brazil, 2017 – 2031

Figure 66: Latin America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Mexico, 2017 – 2031

Figure 67: Latin America Regenerative Therapies Market Absolute $ Opportunity, by Mexico, 2017 – 2031

Figure 68: Latin America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Rest of Latin America, 2017 – 2031

Figure 69: Latin America Regenerative Therapies Market Absolute $ Opportunity, by Rest of Latin America, 2017 – 2031

Figure 70: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Allograft tissue type segment, 2022 – 2031

Figure 71: North America Regenerative Therapies Market Absolute $ Opportunity, by Allograft tissue type segment, 2017 – 2031

Figure 72: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Xenograft tissue type segment, 2022 – 2031

Figure 73: North America Regenerative Therapies Market Absolute $ Opportunity, by Xenograft tissue type segment, 2017 – 2031

Figure 74: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Alloplast tissue type segment, 2022 – 2031

Figure 75: North America Regenerative Therapies Market Absolute $ Opportunity, by Alloplast tissue type segment, 2017 – 2031

Figure 76: Latin America Regenerative Therapies Market Attractiveness Analysis, by Country, 2022 – 2031

Figure 77: Latin America Regenerative Therapies Market Attractiveness Analysis, by Tissue Type, 2022 – 2031

Figure 78: Latin America Regenerative Therapies Market Attractiveness Analysis, by Application, 2022 – 2031

Figure 79: Latin America Regenerative Therapies Market Attractiveness Analysis, by End User, 2022 – 2031

Figure 80: Europe Regenerative Therapies Market Value Share & BPS Analysis, by Country, 2021, 2022 & 2031

Figure 81: Europe Regenerative Therapies Market Y-o-Y Growth Comparison, by Country, 2021 – 2031

Figure 82: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Germany, 2017 – 2031

Figure 83: Europe Regenerative Therapies Market Absolute $ Opportunity, by Germany, 2017 – 2031

Figure 84: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by U.K., 2017 – 2031

Figure 85: Europe Regenerative Therapies Market Absolute $ Opportunity, by U.K., 2017 – 2031

Figure 86: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by France, 2017 – 2031

Figure 87: Europe Regenerative Therapies Market Absolute $ Opportunity, by France, 2017 – 2031

Figure 88: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Spain, 2017 – 2031

Figure 89: Europe Regenerative Therapies Market Absolute $ Opportunity, by Spain, 2017 – 2031

Figure 90: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Italy, 2017 – 2031

Figure 91: Europe Regenerative Therapies Market Absolute $ Opportunity, by Italy, 2017 – 2031

Figure 92: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Russia, 2017 – 2031

Figure 93: Europe Regenerative Therapies Market Absolute $ Opportunity, by Russia, 2017 – 2031

Figure 94: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Rest of Europe, 2017 – 2031

Figure 95: Europe Regenerative Therapies Market Absolute $ Opportunity, by Rest of Europe, 2017 – 2031

Figure 96: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Allograft tissue type segment, 2017 – 2031

Figure 97: Europe Regenerative Therapies Market Absolute $ Opportunity, by Allograft tissue type segment, 2017 – 2031

Figure 98: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Xenograft tissue type segment, 2017 – 2031

Figure 99: Europe Regenerative Therapies Market Absolute $ Opportunity, by Xenograft tissue type segment, 2017 – 2031

Figure 100: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Alloplast tissue type segment, 2017 – 2031

Figure 101: Europe Regenerative Therapies Market Absolute $ Opportunity, by Alloplast tissue type segment, 2017 – 2031

Figure 102: Europe Regenerative Therapies Market Attractiveness Analysis, by Country, 2022 – 2031

Figure 103: Europe Regenerative Therapies Market Attractiveness Analysis, by Tissue Type, 2022 – 2031

Figure 104: Europe Regenerative Therapies Market Attractiveness Analysis, by Application, 2022 – 2031

Figure 105: Europe Regenerative Therapies Market Attractiveness Analysis, by End User, 2022 – 2031

Figure 106: APAC Regenerative Therapies Market Value Share & BPS Analysis, by Country, 2021, 2022 & 2031

Figure 107: APAC Regenerative Therapies Market Y-o-Y Growth Comparison, by Country, 2021 – 2031

Figure 108: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Greater China, 2017 – 2031

Figure 109: APAC Regenerative Therapies Market Absolute $ Opportunity, by Greater China, 2017 – 2031

Figure 110: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by India, 2017 – 2031

Figure 111: APAC Regenerative Therapies Market Absolute $ Opportunity, by India, 2017 – 2031

Figure 112: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Japan, 2017 – 2031

Figure 113: APAC Regenerative Therapies Market Absolute $ Opportunity, by Japan, 2017 – 2031

Figure 114: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Singapore, 2017 – 2031

Figure 115: APAC Regenerative Therapies Market Absolute $ Opportunity, by Singapore, 2017 – 2031

Figure 116: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Australia & New Zealand , 2017 – 2031

Figure 117: APAC Regenerative Therapies Market Absolute $ Opportunity, by Australia & New Zealand , 2017 – 2031

Figure 118: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Taiwan, 2017 – 2031

Figure 119: APAC Regenerative Therapies Market Absolute $ Opportunity, by Taiwan, 2017 – 2031

Figure 120: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by South Korea, 2017 – 2031

Figure 121: APAC Regenerative Therapies Market Absolute $ Opportunity, by South Korea, 2017 – 2031

Figure 122: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Rest of APAC, 2017 – 2031

Figure 123: APAC Regenerative Therapies Market Absolute $ Opportunity, by Rest of APAC, 2017 – 2031

Figure 124: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Allograft tissue type segment, 2017 – 2031

Figure 125: APAC Regenerative Therapies Market Absolute $ Opportunity, by Allograft tissue type segment, 2017 – 2031

Figure 126: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Xenograft tissue type segment, 2017 – 2031

Figure 127: APAC Regenerative Therapies Market Absolute $ Opportunity, by Xenograft tissue type segment, 2017 – 2031

Figure 128: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Alloplast tissue type segment, 2017 – 2031

Figure 129: APAC Regenerative Therapies Market Absolute $ Opportunity, by Alloplast tissue type segment, 2017 – 2031

Figure 130: APAC Regenerative Therapies Market Attractiveness Analysis, by Country, 2022 – 2031

Figure 131: APAC Regenerative Therapies Market Attractiveness Analysis, by Tissue Type, 2022 – 2031

Figure 132: APAC Regenerative Therapies Market Attractiveness Analysis, by Application, 2022 – 2031

Figure 133: APAC Regenerative Therapies Market Attractiveness Analysis, by End User, 2022 – 2031

Figure 134: MEA Regenerative Therapies Market Value Share & BPS Analysis, by Country, 2022 & 2031

Figure 135: MEA Regenerative Therapies Market Y-o-Y Growth Comparison, by Country, 2022 – 2031

Figure 136: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), by GCC countries, 2017 – 2031

Figure 137: MEA Regenerative Therapies Market Absolute $ Opportunity, by GCC countries, 2017 – 2031

Figure 138: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), by S. Africa, 2017 – 2031

Figure 139: MEA Regenerative Therapies Market Absolute $ Opportunity, by S. Africa, 2017 – 2031

Figure 140: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), by Rest of MEA, 2017 – 2031

Figure 141: MEA Regenerative Therapies Market Absolute $ Opportunity, by Rest of MEA, 2017 – 2031

Figure 142: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), by Allograft tissue type segment, 2017 – 2031

Figure 143: MEA Regenerative Therapies Market Absolute $ Opportunity, by Allograft tissue type segment, 2017 – 2031

Figure 144: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), by Xenograft tissue type segment, 2017 – 2031

Figure 145: MEA Regenerative Therapies Market Absolute $ Opportunity, by Xenograft tissue type segment, 2017 – 2031

Figure 146: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), by Alloplast tissue type segment, 2017 – 2031

Figure 147: MEA Regenerative Therapies Market Absolute $ Opportunity, by Alloplast tissue type segment, 2017 – 2031

Figure 148: MEA Regenerative Therapies Market Attractiveness Analysis, by Country, 2022 – 2031

Figure 149: MEA Regenerative Therapies Market Attractiveness Analysis, by Tissue Type, 2022 – 2031

Figure 150: MEA Regenerative Therapies Market Attractiveness Analysis, by Application, 2022 – 2031

Figure 151: MEA Regenerative Therapies Market Attractiveness Analysis, by End User, 2022 – 2031

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

Regenerative Therapies Market: Report Scope

This Persistence Market Research report examines the regenerative therapies market for the period 2021 - 2031. The primary objective of the report is to offer insights into developments in the regenerative therapies market that are significantly helping transform the growth trajectory of global businesses and enterprises associated with the same.

Regenerative therapies entail the application of specific types of cells or cell products for diseased tissues or organs, which ultimately help restore usual tissue and organ function. It also includes the possibility of growing tissues and organs in the laboratory and safely implanting them when the body cannot heal itself.

The regenerative therapies market holds major potential in the near future, which is attributed to the increasing application of these therapies in the treatment of various classes of diseases. The prime factor responsible for the same is the collaborative R&D efforts undertaken by researchers and manufacturers to develop and introduce newer and more efficient therapies.

Orthopedic, cardiovascular, and soft tissue repair are the three main application segments in the global regenerative therapies market. Recently, there has been an alarming rise in the incidence rate of these disorders across the globe. Soft tissue repair and skin restoration therapies are currently the most widely adopted regenerative therapies globally.

Surge in government support and funding from various organizations for R&D related to regenerative therapies over the last few years and increasing incidences of chronic diseases are among the major factors driving growth of the global regenerative therapies market currently.

The regenerative therapies market is segmented as:

  • Tissue Type
  • Application
  • End User
  • Region

This report covers the global regenerative therapies market performance in terms of revenue contribution from various segments. This section also includes Persistence Market Research’s analysis of the key trends, drivers, restraints and opportunities, which are influencing growth of the global regenerative therapies market currently.

Impact analysis of the key growth drivers and restraints is also included in this report to better equip clients with crystal clear decision-making insights.

The regenerative therapies market report begins with an overview of the regenerative therapies procedures, covering the reasons why the patients are increasingly adopting these therapies. This section also underlines factors influencing growth of the regenerative therapies market currently, along with detailed analysis of the key trends, drivers, restraints, opportunities and regulations.

Impact analysis of the key regional growth drivers and restraints based on the weighted average model, coupled with key region-specific trends, is included in report to better equip clients with information and hidden insights.

The global regenerative therapies market is segmented based on tissue type into allografts, xenografts, and alloplasts. Based on application type, the market has been segmented into soft tissue repair, cardiovascular, dental, orthopedic, CNS disease treatment, and others. Based on end user, the market has been segmented into hospitals, ambulatory surgical centers, and educational institutes.

A detailed analysis of every segment has been presented in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index and BPS analysis. Among the various tissue types, allografts are expected to emerge as the product of choice both among surgeons and patients worldwide. Xenografts are also expected to gain popularity over the forecast period.

The next section of the report highlights the growth trends in the regenerative therapies market, by region. It provides the market outlook for 2021–2031 and sets the forecast within the context of the regenerative therapies market. The study discusses the key regional trends contributing to growth of the regenerative therapies market worldwide, as well as analyses the extent to which drivers are influencing this market in each region.

Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific and the MEA. North America is expected to emerge as the most dominant and most attractive market over the forecast period.

The above sections – by tissue type, by application, by end user, and by region – evaluate the present scenario and growth prospects of the regenerative therapies market for the period 2021 - 2031. We have considered 2020 as the base year and provided data for the forecast period.

Detailed company profiles include company-specific long-term and short-term strategies, key offerings, and recent developments by the concerned companies in the regenerative therapies market.

Recommendations

Behenyl Alcohol Market

The behenyl alcohol market has seen steady demand from the cosmetics industry. Moreover, globally, per capita consumption of cosmetics is increasing at a rate of 3.4% per year.

Methyl Ethyl Ketone Market

The expected value of the global MEK market is expected to be US$ 800.2 Mn in 2018 and the market is estimated to reach US$ 1,055.6 Mn by the end of forecast period..

Emea Dearomatic Solvents Market

Global De-aromatic solvents market is expected to register a CAGR of 5.0% over the forecast period (2016 – 2024), to reach valuation of US$ 556.0 Mn by 2024.

Asia Pacific North America Europe Fluorinated Solvents Market

The Asia Pacific Fluorinated Solvents market is expected to register a CAGR of 9.0% over the forecast period (2018–2026)..

Our Clients

Our Clients